Last updated at 02 Jul 2024 02:11 PM
Director
DIN: 06891303
Ved Parkash Thakral is currently associated with 3 companies in various capacities such as Additional Director, Designated Partner, Individual Promoter and Director. They serve as a Director at SUPARSHVA DEVELOPERS LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06891303.Ved Parkash Thakral is currently involved in 4 different roles. Their most recent position is with JD HEALTHCARE PRIVATE LIMITED as a Individual Promoter. The first company Ved Parkash Thakral was appointed to as a director was SUPARSHVA DEVELOPERS LIMITED. Ved Parkash Thakral is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ved Parkash Thakral is currently associated with 3 companies in various capacities such as Additional Director, Designated Partner, Individual Promoter and Director. They serve as a Director at SUPARSHVA DEVELOPERS LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06891303.Ved Parkash Thakral is currently involved in 4 different roles. Their most recent position is with JD HEALTHCARE PRIVATE LIMITED as a Individual Promoter. The first company Ved Parkash Thakral was appointed to as a director was SUPARSHVA DEVELOPERS LIMITED. Ved Parkash Thakral is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (0)
2y 4m 1y 2m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SUPARSHVA DEVELOPERS LIMITED | Additional Director | 02-Jun-2014 |
| JD HEALTHCARE PRIVATE LIMITED | Individual Promoter | 25-Nov-2021 |
| JD HEALTHCARE PRIVATE LIMITED | Director | 25-Nov-2021 |